Aurinia Pharmaceuticals Inc | ||||
NGM : AUPH || Location: Canada | ||||
$5.01+0.01 (+0.2%) |
1.38 M | 4.97 - 5.04 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 10.647 M |
Feb. 29, 2024 | 12.100 M |
Feb. 15, 2024 | 16.853 M |
Jan. 31, 2024 | 18.530 M |
Jan. 12, 2024 | 16.388 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.17 | -0.19 | -14.05% |
09/30/2023 | -0.17 | -0.09 | 47.21% |
06/30/2023 | -0.19 | -0.08 | 57.22% |
03/31/2023 | -0.23 | -0.18 | 20.32% |
12/31/2022 | -0.28 | -0.18 | 35.32% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 144.618M | Shares Float | 131.742M |
Short Float | 10.647M | Market Cap | 724.54M |
Institution ownership | 38.61% | Insider ownership | 7.446% |
Earnings Date | 05/02/2024 BMO | Cash Per Share | ? |
Trailing EPS | -0.54 | Forward EPS | 0.39 |